Best practice in the treatment of advanced squamous cell lung cancer
The management of advanced stage nonsmall cell lung cancer (NSCLC) has been altered by the recognition of histology-based treatment and the use of targeted therapy. Whilst outcomes have improved with adenocarcinoma, treatment options are still limited in advanced stage squamous cell lung cancer. Wit...
Main Authors: | Yvonne L. E. Ang, Hon-Lyn Tan, Ross A. Soo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-10-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465815581147 |
Similar Items
-
Treatment of Advanced Squamous Cell Lung Cancer
by: Yixiang ZHU, et al.
Published: (2016-10-01) -
Progress in Treatment of Advanced Squamous Cell Lung Cancer
by: Ming GAO, et al.
Published: (2020-10-01) -
The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
by: Jia Li Low, et al.
Published: (2019-08-01) -
Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer
by: Ang YLE, et al.
Published: (2016-05-01) -
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
by: Hirsh V
Published: (2017-05-01)